Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by sometoaston May 25, 2007 5:00am
301 Views
Post# 12836747

RE: The market is allways right!!!!

RE: The market is allways right!!!!Piper: As shown in the news release below, BNC started this project 7 years ago (not 4 or 5 years ago as implied in the McRae interview that you cite). BNC's consistent missing of timelines is likely part of the reason why the market has little faith in their predictions. Back then McRae was telling investors commercialization would be a year or two away. News Release New E.coli vaccine to be produced in Canada 20/09/00 Canadian strategic alliance prepares to commercialize cattle vaccine - September 20, 2000 -- (Belleville, Ontario) – The University of British Columbia (UBC), the Alberta Research Council Inc. (ARC), the Veterinary Infectious Disease Organization (VIDO) and Bioniche Life Sciences Inc. today announced the formation of a strategic alliance to complete the development and commercialization of a cattle vaccine able to reduce the threat of Escherichia coli 0157:H7. This deadly strain of E. coli was responsible for the Walkerton, Ontario crisis in May of this year. Six people died and several thousand people in the Walkerton area fell ill when the local water supply was found to be contaminated.
Bullboard Posts